Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

The Proteomics Core Facility provides comprehensive infrastructure for protein identification, characterization, and quantitation using mass spectrometry-based approaches. Our mission is to support ...

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

This multidisciplinary project integrates computational biology, structural modelling, population genomics, and AI. It will provide new mechanistic insights into how coding variation and PTMs ...

This application note demonstrates significant improvements in peak shape, reproducibility, and resolution for challenging ...

Itaconate and its derivatives regulate immune signaling in activated macrophages by modulating both pro-inflammatory and anti-inflammatory pathways. 4-Octyl itaconate stabilizes NFE2L2 by alkylating ...

The breakthrough of AlphaFold2 delivered structural models for nearly all proteins lacking experimental structures, opening new avenues to interrogate both sequence and structure. However, these ...

Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations to disease. The method, called DeepMVP and ...